Substrate-Controlled Direct α-Stereoselective Synthesis of Deoxyglycosides from Glycals Using B(C <sub>6</sub> F <sub>5</sub> ) <sub>3</sub> as Catalyst by Sau, Abhijit et al.
                          Sau, A., Palo-Nieto, C., & Galan, M. C. (2019). Substrate-Controlled Direct -
Stereoselective Synthesis of Deoxyglycosides from Glycals Using B(C 6F 5)
3as Catalyst. Journal of Organic Chemistry, 84(5), 2415-2424.https://doi.org/10.1021/acs.joc.8b02613
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1021/acs.joc.8b02613
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via ACS at
https://doi.org/10.1021/acs.joc.8b02613 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Substrate-Controlled Direct α‑Stereoselective Synthesis of
Deoxyglycosides from Glycals Using B(C6F5)3 as Catalyst
Abhijit Sau, Carlos Palo-Nieto, and M. Carmen Galan*
School of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
*S Supporting Information
ABSTRACT: B(C6F5)3 enables the metal-free unprece-
dented substrate-controlled direct α-stereoselective synthesis
of deoxyglycosides from glycals. 2,3-Unsaturated α-O-glyco-
side products are obtained with deactivated glycals at 75 °C in
the presence of the catalyst, while 2-deoxyglycosides are
formed using activated glycals that bear no leaving group at C-
3 at lower temperatures. The reaction proceeds in good to
excellent yields via concomitant borane activation of glycal
donor and nucleophile acceptor. The method is exempliﬁed
with the synthesis of a series of rare and biologically relevant glycoside analogues.
■ INTRODUCTION
Deoxyglycosides are an important class of carbohydrates
commonly found in nature as part of biologically active
glycoconjugates.1 These compounds are characterized by the
lack of substitution at one or several positions around the
carbohydrate ring, often at C-2, which makes them more
challenging to synthesized than their fully oxygenated counter-
parts. The absence of directing groups adjacent to the
anomeric center to bias the nucleophile approach during the
glycosylation reaction, often leads to mixtures of anomers and/
or Ferrier-type products.2 Owing to their relevance in drug
discovery, research eﬀorts have focused in achieving their
stereoselective synthesis.3
Coupling reactions involving glycals are one of the most
atom-eﬃcient routes to access deoxyglycosides.4 Traditional
methods to yield the corresponding 2-deoxyglycoside rely on
acid catalyzed direct addition of an alcohol to the glycal, which
often leads to either moderate to low yields and/or variable
selectivities which are dependent on the nature of the OH
nucleophile (e.g., primary vs secondary, axial vs equatorial)
with 2,3-unsaturated glycosides and hydrolyzed starting
material as common side products.2a,3a,q However, most acid-
catalyzed processes to access 2,3-unsaturated glycosides
directly, which are also versatile synthons in organic
chemistry,5 tend to use harsh promoters, required speciﬁc
protected building blocks, and often lead to moderate overall
yields and diastereocontrol, which has limited their utility.3a
Given the range of glycoside donor and OH nucleophile
reactivity proﬁles, there is currently no universal Lewis acid
glycosylation promoter that can be used for the activation of
glycals.3 Thus, there is a need to ﬁnd improved and more
general catalysts to access these high value glycosides.
Our group has been interested over the past few years in the
development of practical, selective and catalytic methods for
the direct activation of glycals using thiourea-based organo-
catalysts,4b−d as well as palladium and gold catalytic activators.9
Encouraged by our previous work, we undertook synthetic
studies toward the development of a metal-free and improved
organocatalytic method for the activation of glycals.
Trivalent boron reagents are often employed as Lewis acids
because of their ubiquitous electrophilic nature and ability to
reversibly form bonds with oxygen and thus are attractive
catalysts in glycosylation chemistry including examples in
regioselective glycosylations.3a,p,6 Among the boron-based
Lewis acids available, B(C6F5)3 (BCF) has demonstrated
extensive versatility in a wide variety of reactions including
borylation, hydrogenation, hydrosilylation, frustrated Lewis
pair (FLP) chemistry, and Lewis acid catalysis.7 In the context
of glycosylation chemistry, the utility of BCF has only been
shown in the activation of fully substituted trichloroacetimidate
glycosyl donors in good to excellent yields and moderate to
good diastereoselectivity,8 with no examples reported in the
synthesis of deoxyglycosides.
Herein we describe the metal-free, atom-economic, and
versatile substrate-controlled borane-catalyzed highly α-stereo-
selective synthesis of deoxyglycosides directly from glycals
(Scheme 1).
■ RESULTS AND DISCUSSION
Initial studies began by screening BCF for its ability to
promote the stereoselective glycosylation of peracetylated
galactal 1a with glucoside acceptor 2a in the presence of
diﬀerent catalyst loadings, solvents, and temperatures. It was
found that 5 mol % BCF in toluene at 75 °C was the optimum
condition to yield the corresponding 2,3-unsaturated glycoside
3a after 2 h (88%, α:β 30:1, entry 1 in Table 1). Reactions
were less eﬃcient at lower catalyst loadings or at lower
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temperatures; changing the solvent to CH2Cl2 or CH3CN was
also detrimental to the reaction (see Table S1 in the
Supporting Information (SI) for solvent and temperature
screen details). Having established the optimal reaction
conditions, our attention then turned to exploring the substrate
scope of the reaction between 1a and a range of OH
nucleophiles 2b−2k (Table 1). In all cases, reactions
proceeded smoothly within 1.5−4 h and in good to excellent
yields and a clear preference for the α-products, demonstrating
the reaction is tolerant of primary, secondary, and phenolic
OH nucleophiles, as well as common alcohol protecting groups
(e.g., acetals, ethers, and esters).
Glycosylations with primary alcohols 2b−2e aﬀorded the
corresponding 2,3-unsaturated glycosides in 72−86% yield
within 2 h and with a 30:1 α:β ratio (entries 2−5). Reactions
with secondary alcohols such as 4-methoxyphenol 2i,
cholesterol 2j, or N-hydroxysuccinimide 2k (entries 9−11)
proceeded smoothly giving the desired products in similar high
α-selectivity (>30:1 to >20:1, α/β ratio) and yields of 77−
82%. Reactions with glycosides 2g, 2h, and propargyl alcohol
2f (entries 6−8) prove to be more challenging and aﬀorded the
products in lower yields and stereoselectivity, albeit in favor of
the α-products (67−86%, 6:1−7:1 α:β ratio). The ability to
eﬀectively activate galactals is noteworthy, as generally glycal
substrates that favor a bigger shift toward 5H4 conformations
(e.g., glucals) undergo rearrangement more readily than their
C-4 epimer galactals where the equilibria is shifted toward the
4H5 form and as a result galactals often give mixtures of
products, as well as lower overall yields.10
The scope of the reaction was further investigated with
regards to glycal donor. To this end, a series of peracetylated
glycals: D-glucal 1b, L-fucal 1c, D-xylal 1d and L-rhamnal 1e
were subjected to the reaction conditions with 2e as the model
OH nucleophile (Scheme 2). In general, moderate to good
yields (65−86%) and α-selectivities were obtained in all cases
leading to the formation of 2-deoxy and 2,6-dideoxy Ferrier-
type products. Best diastereoselectivities were observed for 2,6-
dideoxyglycals (15:1−30:1 α:β, 1c-1e), while glucal 1b yielded
4b in 86% yield and a 3:1 α:β ratio.
The synthetic utility of our strategy was further exempliﬁed
on the preparation of rare glycoside analogues 6−8, which are
often diﬃcult to access by traditional methods11 bearing a Boc-
protected amino propyl linker that could be used for array
conjugation (Scheme 3). Glycosylation of 3-(Boc-amino)-1-
propanol with 1c, followed by ester deprotection gave 2,3-
unsaturated fucoside 5 in 83% yield (2 steps) and a 10:1 α/β
ratio. Alkene reduction of 5 with Rh−Al2O3 aﬀorded α-L-
Rhodinose 6 in 76% yield. Alternatively, subjecting 5 to
reduction followed by treatment with Dess-Martin periodinane
gave α-L-cinerulose 7 (55%), while direct alcohol oxidation of
5 yields α-L-aculose 8 (79%).
Next, we explored whether “armed” glycosides lacking a
leaving group at C-3 could undergo BCF-activation and give
substitution products selectively. To probe this, reactions
between perbenzylated galactal 9a, acceptor 2a and BCF were
screened at diﬀerent catalyst loadings, solvents and temper-
atures as before. Best results were found when 5 mol %
B(C6F5)3 was used in toluene at 50 °C to give 2-
deoxyglycoside 10a after 2 h (88%, α/β > 30:1, entry 1,
Table 2). As before, reactions were less eﬃcient at lower
catalyst loadings or temperatures below 50 °C and changing
Scheme 1. BCF-Catalysed Synthesis of 2,3-Unsaturated
Glycosides from “Disarmed” Glycals (Pathway A) and 2-α-
Deoxyglycosides from “armed” Glycals (Pathway B)
Table 1. Glycosylation Reactions with Galactal 1ac
aIsolated yield. bDetermined by 1H-NMR. cReaction did not proceed
in the absence of catalyst. dActivation with BF3.OEt2 aﬀorded 3a in
19% as a 6:1 mixture of anomers.
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the solvent to CH2Cl2, CH3CN or CF3Ph was also detrimental
(SI Table S2 for full details).
To explore the substrate scope of the glycosylation, galactals
9b−d and glucals 11a−c were reacted with a range of primary
and secondary OH nucleophiles 2a, 2e, or 2g under the
optimized reaction conditions. In all cases, reactions proceeded
smoothly in yields of 62−94% and high α-selectivity (20:1−
30:1 α:β), with secondary OHs requiring longer reaction times
(entries 4 and 5 vs 1−3). Subsequently, a series of diﬀerentially
protected galactals 9b−d and glucals 11a−c bearing benzyl,
methoxymethyl acetal, silyl ethers and acetals, and siloxane
protecting groups were prepared and subjected to the reaction
conditions to investigate the eﬀect of glycal donor on the
reaction. Pleasingly, reactions involving all galactals were
complete within 1−7 h, in good yields (71−82%) and high α-
selectivities (20:1 to 30:1 α/β) (entries 6−8). The reaction
was also amenable to glycosylations with glucal substrates,
albeit required longer reaction times (17 h) and aﬀorded the
glycoside products in moderate to good yields (54−86%) with
similarly high α-stereocontrol. Siloxane protected donors 11b
and 11c gave better yields that perbenzylated glucal 11a
(entries 9−13) as expected.4c These results further highlight
that the catalytic system works well across a range of reactivity
proﬁles in both the glycal moiety and nucleophile acceptor.
Scheme 2. Reaction of Glycals 1a−1e, with Glycosyide
Acceptors 2e
Scheme 3. Synthesis of Rare Glycosides 6−8
Table 2. Reaction of Glycals 9a−d and 11a−c with Model Glycosyide Acceptors 2a, 2e, or 2g
entry R1 R2 R3 product time (h) yield (%)a α/βb
1 9a Bn Bn Bn 10a 1 88d,e 21:1
2 9a Bn Bn Bn 10c 1 94 26:1
3 9a Bn Bn Bn 10e 2 84 30:1
4 9a Bn Bn Bn 10g 7 62 25:1
5 9a Bn Bn Bn 10h 7 68 20:1
6 9b TBS TBS TBS 11b 1 92 30:1
7 9c MOM MOM MOM 11c 1 71 20:1
8 9d Si(tBu)2 MOM 11d 1 82 20:1
9 11a Bn Bn Bn 12ac 17 54 30:1
10 11b O[Si(i-Pr)2]2 Bn 12b 17 78 30:1
11 11c O[Si(i-Pr)2]2 TIPS 12c 17 75 30:1
12 11c O[Si(i-Pr)2]2 TIPS 13 17 86 30:1
13 11c O[Si(i-Pr)2]2 TIPS 14 17 64 20:1
aIsolated yield. bDetermined by 1H NMR. c10% Ferrier product 12a′ also isolated. dReaction did not proceed in the absence of catalyst. eReaction
with BF3.OEt2 aﬀorded 10a (<35%) and a mixture of products and starting material.
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To probe the mechanism of this versatile reaction,
deuterated perbenzylated galactal 15 was reacted with 2a to
yield α-glycoside 16a and 16b (90% yield) as a 2:1 mixture of
cis/trans products, with a preference for syn addition of both
H and O-nucleophile across the double bond (Scheme 4A).
Addition of K2CO3 to the reaction between either 1a or 9a
with 2a inhibited the reaction, which supports an acid
catalyzed process. Monitoring the reaction between 1a or 9a
and hexaﬂuoroisopropanol 17 (Scheme 4B) by 1H NMR over
60 min at 45 °C or 90 min at RT, respectively, only showed
anomeric signals corresponding to the starting material and
product, without any observable changes in the anomeric ratio
of the product throughout the time scales of the reaction (SI
Figures S1 and S3).13 Moreover, subjecting a 4:1 α/β-
anomeric mixture of 10a to the reaction conditions in the
presence of acceptor 2a gave no change in the anomeric ratio
(see SI for details). These results suggest the reaction proceeds
via short-lived intermediates and that the high α-selectivity is
not likely the result of anomerization. 19F-NMR of the
reactions (SI Figures S2 and S4) showed the appearance of
ﬂuorinated signals assigned to products 18 and 19,
respectively, and also shifts associated with the formation of
other BCF species, suggesting the presence of BCF-adducts.
Moreover, 1H NMR spectroscopy studies in Toluene-d8 of a
1:1 mixture of BCF with galactal donor 1a or 9a, also showed
H-shifts associated with the enol ether alkene protons, in each
case (SI Figures S5 and S7). 19F-NMR of the same mixtures
showed additional signals associated with several distinct BCF-
species (SI Figures S6 and S8), suggesting activation of the
glycal enol ethers by BCF can take place and formation of
adducts. Interestingly, 1H NMR equimolar mixtures of
B(C6F5)3 and OH nucleophile 2a at room temperature
showed proton shifts associated with 2a (Figure S9). This
eﬀect was more evident in the 19F-NMR spectra of the same
mixtures (SI Figure S10) which showed the shift of the ﬂuorine
signals from the catalysts and appearance of diﬀerent
ﬂuorinated species, further supporting the formation of an
adduct between the catalyst and the OH nucleophile. This is in
agreement to previous reports of glycosyl acceptor activation
with boron-based catalysts such as BCF and PhBF2 in the
acid−base activation of trichloroacetimidate glycosyl do-
nors.8b,12
As our preliminary ﬁndings suggest, BCF could act as a
Lewis acid to promote the eﬀective allylic rearrangement13 (A)
of deactivated glycals such as 1a to form transient
oxocarbenium ion (B) that can undergo nucleophilic
substitution by the BCF-activated nucleophile adduct (H
BCFOR) in a stereoselective manner to give 2,3-unsaturated
glycosides. In the presence of more reactive glycals, which lack
a leaving group at C-3 (e.g., 9a), enol ether direct activation to
form oxacarbenium ion (D) might take place, which after
nucleophilic substitution by the BCF-activated nucleophile and
concomitant protonolysis leads to deoxyglycoside products. In
both instances, there is a clear preference for an α-face
nucleophilic approach, likely due to sterics and a favorable
anomeric eﬀect14 (Scheme 5, top). However, in the presence
of Lewis basic oxygen atoms, BCF coordination to the pyran
oxygen in the donor is also possible. Therefore, an acid−base
catalyzed mechanism whereby the boron ate adduct promotes
both oxocarbenium ion formation and nucleophile activation
can not be discarded and it is likely to occur in parallel
(Scheme 5, bottom). Further investigations are ongoing to
better understand the mechanism of this reaction.
■ CONCLUSIONS
In summary, we have described the unprecedented BCF-
catalyzed substrate-controlled stereoselective synthesis of α-
deoxyglycosides directly from glycals. We show that 2,3-
unsaturated α-O-glycoside products are obtained with
deactivated glycals at 75 °C, while 2-α-deoxyglycosides are
formed with activated glycals lacking a leaving group at C-3 at
slightly lower temperatures. This metal-free and versatile
reaction is applicable to a range of glycal donors and
nucleophile acceptors, and is tolerant of most common
protecting groups. The reaction proceeds with good to
excellent yields and high selectivity for the α-anomer. We
exemplify the robustness and utility of the approach in the
stereoselective synthesis of a series of oligosaccharides,
glycosyl-amino acids, and other glyco-conjugates including
rare glycosides analogues of α-L-Rhodinose α-L-cinerulose and
α-L-aculose. Work from our lab is currently underway to
exploit this chemistry for the stereoselective synthesis of other
important glycosides.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Chemicals were purchased
and used without further puriﬁcation. Glycal donors 1a−1e, 9a, and
11a were purchased from Carbosynth and OH acceptors 2b, 2e, 2f,
Scheme 4. Model Glycosylations of 2a or 17 with Glycal
Donors 15, 1a, or 9a
Scheme 5. Proposed Mechanism
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2h, 2i, 2j, and 2k were obtained from Sigma-Aldrich. Galactal donors
9b and 9c and glycosyl acceptors 2a, 2c, and 2d were prepared
following literature procedures,4d while glucal 11b and 11c and
glycosyl acceptor 2g were synthesized by Balmond et al. reported
methods.4c Dry solvents were obtained by distillation using standard
procedures or by passage through a column of anhydrous alumina
using equipment from Anhydrous Engineering (University of Bristol)
based on the Grubbs’ design. Reactions requiring anhydrous
conditions were performed under nitrogen; glassware and needles
were either ﬂame-dried immediately prior to use or placed in an oven
(150 °C) for at least 2 h and allowed to cool either in a desiccator or
under reduced pressure; liquid reagents, solutions, or solvents were
added via syringe through rubber septa; solid reagents were added via
Schlenk type adapters. Teﬂon rings were used between the joints of
the condensers and round-bottom ﬂasks. Reactions were monitored
by TLC on Kieselgel 60 F254 (Merck). Detection was by examination
under UV light (254 nm) and by charring with 10% sulfuric acid in
ethanol. Flash column chromatography was performed using silica gel
[Merck, 230−400 mesh (40−63 μm)]. Extracts were concentrated in
vacuo using both a Büchi rotary evaporator (bath temperatures up to
40 °C) at a pressure of either 15 mmHg (diaphragm pump) or 0.1
mmHg (oil pump), as appropriate, and a high vacuum line at room
temperature. 1H NMR and 13C NMR spectra were measured in the
solvent stated at 400 or 500 MHz. Chemical shifts are quoted in parts
per million from residual solvent peak (CDCl3:
1H−7.26 ppm and
13C−77.16 ppm) and coupling constants (J) given in Hertz.
Multiplicities are abbreviated as b (broad), s (singlet), d (doublet),
t (triplet), q (quartet), m (multiplet), or combinations thereof. Mass
spectra were determined by the University of Bristol mass
spectrometry service by electrospray ionization (SI) modes. The
units of the speciﬁc rotation, (deg·mL)/(g·dm), are implicit and are
not included with the reported value. Concentration c is given in g/
100 mL.
General Glycosylation Procedure. Glycal donor (1.0 equiv),
OH nucleophile acceptor (0.75 equiv), and B(C6F5)3 (5 mol %) were
weighed into an oven-dried microwave vial, sealed and placed under
vacuum for 1 h. Then the vial was ﬁlled with N2 followed by the
addition of ∼1.0 mL of anhydrous toluene. The solutions were stirred
and heated at 75 °C for Ferrier glycosylation and 50 °C for 2-deoxy
glycosylation until the reaction was determined to be complete by
either TLC or NMR analysis of the crude material (times are given in
Tables S1 and S2 and Tables 1 and 2 of the main manuscript). The
reaction mixture was concentrated in vacuo and the dried residue was
puriﬁed by silica gel column chromatography.
Methyl-6-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-eno-
pyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 3a). Following
the general glycosylation procedure, donor 1a (50 mg, 0.18 mmol),
B(C6F5)3 (5 mg 0.01 mmol), and acceptor 2a (64 mg, 0.14 mmol) to
aﬀord following puriﬁcation by silica gel column chromatography
(Hexane:EtOAc, 6:1 to 3:1) 3a as a colorless oil (82 mg, 88%).
Spectroscopic data in agreement with literature.15
Benzyl-4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-enopyrano-
side (3b). Following the general glycosylation procedure, donor 1a
(50 mg, 0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2b
(15 mg, 0.14 mmol) to aﬀord following puriﬁcation by column
chromatography (Hexane:EtOAc, 12:1 to 8:1) 3b as a colorless oil
(37 mg, 84%). Spectroscopic data in agreement with literature.15
Methyl-6-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-eno-
pyranosyl)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (3c). Following
the general glycosylation procedure, donor 1a (50 mg, 0.18 mmol),
B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2c (70 mg, 0.14 mmol) to
aﬀord following puriﬁcation by silica gel column chromatography
(Hexane: EtOAc, 5:1 to 2:1) 3c as a colorless oil (72 mg, 72%). 1H
NMR (500 MHz, CDCl3) δ 7 δ 7.98 (dd, J = 18.7, 7.7 Hz, 5H, Ar−
H), 7.87 (d, J = 7.8 Hz, 2H, Ar−H), 7.55−7.52 (m, 2H, Ar−H), 7.39
(t, J = 7.7 Hz, 4H, Ar−H), 7.32−7.28 (m, 2H, Ar−H), 6.20−6.09 (m,
2H, H-2, H-2’), 6.04 (dd, J = 10.0, 3.0 Hz, 1H, H-3′), 5.72 (t, J = 9.8
Hz, 1H, H-4), 5.30−5.26 (m, 2H, H-1, H-3), 5.13 (d, J = 2.9 Hz, 1H,
H-1’), 5.04 (dd, J = 5.5, 2.5 Hz, 1H, H-4’), 4.39 (ddd, J = 7.8, 5.4, 2.4
Hz, 1H, H-5′), 4.26 (dt, J = 10.4, 3.7 Hz, 1H, H-5), 4.16−3.99 (m,
3H, H-6a, H-6a’, H-6b’), 3.74 (dd, J = 11.1, 3.0 Hz, 1H, H-6b), 3.50
(s, 3H, OCH3), 2.07 (s, 3H, COCH3), 1.86 (s, 3H, COCH3).
13C
NMR (126 MHz, CDCl3) δ 170.5 (COCH3), 170.3 (COCH3), 165.8
(COPh), 165.8 (COPh), 165.2 (COPh), 133.5 (Ar−C), 133.4 (Ar−
C), 133.1 (Ar−C) 130.1 (Ar−C), 129.9 (Ar−C), 129.8 (Ar−C),
129.2 (C-2’), 129.1 (Ar−C), 128.5 (Ar−C), 128.4 (Ar−C), 128.3
(Ar−C), 125.3, (C-3′) 97.1 (C-1), 93.9 (C-1′), 72.1(C-3), 70.6 (C-
2), 69.4 (C-4), 68.3 (C-5), 66.6 (C-5′), 66.1 (C-6), 62.6 (2C- 4′, 6′),
55.7 (OCH3), 20.8 (COCH3), 20.5 (COCH3); ESI-HRMS for
C38H38O14Na
+ (MNa+) calculated: 741.2159; found: 741.2161
Thiophenyl-6-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-
enopyranosyl)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (3d). Fol-
lowing the general glycosylation procedure, donor 1a (50 mg, 0.18
mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2d (80 mg, 0.14
mmol) to aﬀord following puriﬁcation by column chromatography
(Hexane:EtOAc, 5:1 to 1:1) 3d as a colorless oil (85 mg, 72%). 1H
NMR (500 MHz, CDCl3) δ 8.00−7.96 (m, 2H, Ar−H), 7.96−7.91
(m, 2H, Ar−H), 7.82−7.78 (m, 2H, Ar−H), 7.57−7.50 (m, 4H, Ar−
H), 7.41 (m, 5H, Ar−H), 7.35−7.25 (m, 5H, Ar−H), 6.10 (ddd, J =
10.1, 5.5, 1.0 Hz, 1H, H-2’), 5.96 (dd, J = 10.0, 3.1 Hz, 1H, H-3′),
5.91 (t, J = 9.5 Hz, 1H, H-3), 5.63 (t, J = 9.7 Hz, 1H, H-4), 5.49 (t, J
= 9.7 Hz, 1H, H-2), 5.12 (d, J = 3.1 Hz, 1H, H-1’), 5.08 (d, J = 10.0
Hz, 1H, H-1), 4.97 (dd, J = 5.5, 2.5 Hz, 1H, H-4’), 4.32 (ddd, J = 7.8,
5.4, 2.5 Hz, 1H, H-5′), 4.16−4.08 (m, 2H, H-6a′. H-6b′), 4.07−4.00
(m, 2H, H-5, H-6a), 3.83−3.77 (m, 1H, H-6b), 2.08 (s, 3H,
COCH3), 1.93 (s, 3H, COCH3).
13C NMR (126 MHz, CDCl3) δ
170.5 (COCH3), 170.3 (COCH3), 165.8 (COPh), 165.1 (COPh),
165.0 (COPh), 133.5 (Ar−C), 133.2 (Ar−C), 132.6 (Ar−C), 132.1
(Ar−C), 130.1 (C-3′), 129.9 (Ar−C), 129.8 (Ar−C), 129.7 (Ar−C),
129.2 (Ar−C), 128.9 (Ar−C), 128.9 (Ar−C), 128.8 (Ar−C), 128.5
(Ar−C), 128.4 (Ar−C), 128.3 (Ar−C), 128.2 (Ar−C), 125.3 (C-2’),
93.8 (C-1′), 85.9 (C-1), 77.2 (C-5), 74.3 (C-3), 70.5 (C-2), 69.5 (C-
4) 66.7 (C-5′) 66.5 (C-6), 62.7 (C-6′), 62.6 (C-4′), 20.8 (COCH3),
20.6 (COCH3). ESI-HRMS for C43H40O13SNa
+ (MNa+) calculated:
819.2087; found: 819.2103.
6-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-enopyrano-
syl)-1,2:4,5-di-O-isopropylidene-α-D-galacopyranoside (3e). Fol-
lowing the general glycosylation procedure, donor 1a (50 mg, 0.18
mmol), B(C6F5)3 (5 mg 0.01 mmol), and acceptor 2e (36 mg, 0.14
mmol) to aﬀord following puriﬁcation by silica gel column
chromatography (Hexane:EtOAc, 7:1 to 4:1) 3e as a colorless oil
(49 mg, 75%). Spectroscopic data in agreement with literature.15
2′-Propyn-1′-yl-4,6-di-O-acetyl-2,3-dideoxy-α/β-D-threo-hex-2-
enopyranoside (3f). Following the general glycosylation procedure,
donor 1a (50 mg, 0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and
acceptor 2f (7.73 mg, 0.14 mmol) to aﬀord following puriﬁcation by
silica gel column chromatography (Hexane:EtOAc, 8:1 to 4:1) 3f as a
colorless oil (32 mg, 86%). Spectroscopic data in agreement with
literature.15
Methyl 3-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-eno-
pyranosyl)-4,6-O-benzylidene 2-O-benzyl-α-D-glucopyranoside
(3g). Following the general glycosylation procedure, donor 1a (50
mg, 0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2g (51
mg, 0.14 mmol) to aﬀord following puriﬁcation by silica gel column
chromatography (Hexane:EtOAc, 5:1 to 3:1) 3g as a colorless oil (55
mg, 68%)1H NMR (500 MHz, CDCl3) δ 7.42 (dd, J = 6.7, 2.8 Hz,
2H, Ar−H), 7.37−7.32 (m, 7H, Ar−H), 7.32−7.29 (m, 1H, Ar−H),
6.07 (dd, J = 3.2, 1.8 Hz, 2H, H-2′, H-3′), 5.54 (d, J = 2.0 Hz, 1H, H-
1), 5.51 (s, 1H, H-PhCH), 5.00 (dd, J = 4.3, 2.7 Hz, 1H, H-4’), 4.81−
4.69 (m, 1H, PhCHH), 4.57 (d, J = 12.2 Hz, 1H, PhCHH), 4.54 (d, J
= 3.7 Hz, 1H, H-1), 4.51−4.46 (m, 1H, H-5′), 4.41 (t, J = 9.4 Hz, 1H,
H-3), 4.25 (ddt, J = 13.2, 7.3, 3.3 Hz, 2H, H-6a′, H-6a), 4.05 (dd, J =
11.2, 7.2 Hz, 1H, H-6b’), 3.82 (td, J = 9.9, 4.8 Hz, 1H, H-5), 3.69 (t, J
= 10.3 Hz, 1H, H-6b), 3.56 (t, J = 9.5 Hz, 1H, H-4), 3.46 (ddd, J =
13.1, 9.4, 3.6 Hz, 1H, H-2), 3.35 (s, 3H, OCH3), 2.06 (d, J = 6.1 Hz,
6H, 2 COCH3).
13C NMR (126 MHz, CDCl3) δ 170.8 (COCH3),
170.4 (COCH3), 138.2 (Ar−C), 137.2 (Ar−C), 130.8 (C-3′), 129.0
(Ar−C), 128.4 (Ar−C), 128.3 (Ar−C), 128.1 (Ar−C), 127.9 (Ar−
C), 126.0 (Ar−C), 124.9 (C-2′), 101.4 (C-PhCH), 99.1 (C-1), 93.6
(C-1′), 82.8 (C-4), 78.1 (C-2), 73.4 (C-PhCH2), 73.1 (C-3), 69.1
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(C-6), 66.4 (C-5′), 62.7 (C-4′), 62.2 (C-6′), 62.0 (C-5), 55.2
(OCH3), 20.8 (COCH3), 20.70 (COCH3). ESI-HRMS for
C31H36O11Na
+ (MNa+) calculated: 607.2155; found: 607.2155.
3-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2- enopyrano-
syl)-l,2:5,6-di-O-isopropylidene-α-D-glucofuranose (3h). Following
the general glycosylation procedure, donor 1a (50 mg, 0.18 mmol),
B(C6F5)3 (5 mg 0.01 mmol), and acceptor 2h (36 mg, 0.14 mmol) to
aﬀord following puriﬁcation by silica gel column chromatography
(Hexane:EtOAc, 7:1 to 3:1) 3h as a colorless oil (44 mg, 67%). 1H
NMR (500 MHz, CDCl3) δ 6.16 (ddd, J = 10.0, 5.5, 1.1 Hz, 1H, H-
2’), 6.09−5.99 (m, 1H, H-3′), 5.90 (d, J = 3.6 Hz, 1H, H-1), 5.39−
5.34 (m, 1H, H-1′), 5.04 (dt, J = 5.5, 2.8 Hz, 1H, H-4′), 4.63 (d, J =
3.6 Hz, 1H, H-2), 4.41−4.28 (m, 3H, H-5′, H-3, H-6a′), 4.25−4.18
(m, 2H, H-4, H-6b′), 4.16−4.08 (m, 2H, H-5, H-6a), 3.99 (dd, J =
8.6, 5.1 Hz, 1H, H-6b), 2.13 (s, 3H), 2.10 (s, 3H), 1.52 (s, 3H), 1.42
(s, 3H), 1.33 (d, J = 4.1 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ
170.8 (COCH3), 170.3 (COCH3), 130.0 (C-3′), 125.4 (C-2′), 112.0
(4°C), 109.17(4°C), 105.4 (C-1), 94.9 (C-1′), 84.3 (C-2), 81.3 (C-
4), 80.77 (C-3), 72.7 (C-5), 67.8 (C-6), 67.2 (C-5′), 63.1 (C-6’), 62.8
(C-4′), 27.0 (CCH3), 26.9 (CCH3), 26.5 (CCH3), 25.4 (CCH3), 20.8
(COCH3), 20.7 (COCH3). ESI-HRMS for C22H32O11Na
+ (MNa+)
calculated: 495.1842; found: 495.1832.
4-Methoxyphenyl,4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-hex-2-
enopyranoside (3i). Following the general glycosylation procedure,
donor 1a (50 mg, 0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and
acceptor 2i (17 mg, 0.14 mmol) to aﬀord following puriﬁcation by
silica gel column chromatography (Hexane:EtOAc, 9:1 to 3:1) 3i as a
colorless oil (36 mg, 82%)1H NMR (500 MHz, CDCl3) δ 7.10−7.05
(m, 4H, Ar−H), 6.88−6.83 (m, 2H, Ar−H), 6.27 (ddd, J = 9.9, 5.4,
1.0 Hz, 1H, H-2), 6.21 (dd, J = 10.0, 3.0 Hz, 1H, H-3), 5.64 (dt, J =
3.0, 0.6 Hz, 1H, H-1), 5.13 (dd, J = 5.4, 2.5 Hz, 1H, H-4), 4.54 (ddd,
J = 7.7, 5.3, 2.5 Hz, 1H, H-5), 4.29−4.23 (m, 2H, H-6a, H-6b), 3.80
(s, 3H, OCH3), 2.12 (s, COCH3), 1.98 (s, 3H, COCH3).
13C NMR
(126 MHz, CDCl3) δ 170.6 (COCH3), 170.4 (COCH3), 155.2 (Ar−
C), 151.0 (Ar−C), 129.9 (C-3), 125.9 (C-2), 118.8 (Ar−C), 114.5
(Ar−C), 93.7 (C-1), 67.5 (C-5), 62.6 (C-4), 62.5 (C-6), 55.7
(OCH3), 20.8 (COCH3), 20.7 (COCH3). ESI-HRMS for
C17H20O7Na
+ (MNa+) calculated: 359.1107; found: 359.1117.
Cholesteryl-4,6-diacetyl-2,3-dideoxy-α-D-threo-2-enopyranoside
(3j). Following the general glycosylation procedure, donor 1a (50 mg,
0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2j (53 mg,
0.14 mmol) to aﬀord following puriﬁcation by silica gel column
chromatography (Hexane:EtOAc, 4:1 to 2:1) 3j as a colorless oil (65
mg, 79%) 1H NMR (500 MHz, Chloroform-d) δ 6.12 (dd, J = 10.0,
5.3 Hz, 1H, H-3), 6.03 (dd, J = 10.0, 3.0 Hz, 1H, H-2), 5.38 (dd, J =
4.9, 2.4 Hz, 1H, C = CH), 5.23 (d, J = 3.1 Hz, 1H, H-1), 5.04 (dd, J =
5.4, 2.5 Hz, 1H, H-4), 4.43 (ddd, J = 7.7, 5.6, 2.5 Hz, 1H, H-5), 4.27−
4.20 (m, 2H, H-6a, H-6b), 3.59 (m, 1H), 2.44 (ddd, J = 13.4, 5.2, 2.1
Hz, 1H), 2.39−2.24 (m, 1H), 2.09 (d, J = 5.2 Hz, 6H, 2 COCH3),
2.05−1.95 (m, 3H), 1.93−1.79 (m, 3H), 1.63−1.05 (m, 16H), 1.02
(s, 5H), 0.93 (d, J = 6.5 Hz, 4H), 0.88 (dd, J = 6.6, 2.2 Hz, 8H), 0.69
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 170.7 (COCH3), 170.4
(COCH3), 140.8 (C = CH), 131.2 (C-2), 125.0 (C-3), 121.8 (C =
CH), 92.4 (C-1), 78.0, 66.7 (C-5), 63.0 (2C-6, 4)), 56.8 (CH), 56.2
(CH), 50.2 (CH), 42.3 (4 °C), 40.4 (CH2), 39.8 (CH2), 39.5 (CH2),
37.2 (4 °C), 36.7 (CH2), 36.2 (CH), 35.8, 31.9, 31.9, 28.2, 28.0, 24.3,
23.8, 22.8, 22.6, 21.1 (COCH3), 20.8 (COCH3), 19.3 (CH3), 18.7
(CH3), 11.9 (CH3). ESI-HRMS for C37H58O6Na
+ (MNa+)
calculated: 621.4131; found: 621.4126.
N-Succinimido-4,6-diacetyl-2,3-dideoxy-α-D-threo-2-enopyrano-
side (3k). Following the general glycosylation procedure, donor 1a
(50 mg, 0.18 mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2k
(16 mg, 0.14 mmol) to aﬀord following puriﬁcation by silica gel
column chromatography (Hexane:EtOAc, 3:1 to 1:1) 3k as a colorless
oil (41 mg, 91%). 1H NMR (500 MHz, CDCl3) δ 6.36 (ddd, J = 10.0,
5.6, 1.2 Hz, 1H, H-3), 6.20 (ddd, J = 10.0, 3.1, 0.6 Hz, 1H, H-2), 5.64
(ddd, J = 3.2, 1.2, 0.6 Hz, 1H, H-1), 5.15 (ddd, J = 5.6, 2.7, 0.6 Hz,
1H, H-4), 4.81 (td, J = 6.3, 2.7 Hz, 1H, H-5), 4.33 (dd, J = 11.3, 6.2
Hz, 1H, H-6a), 4.07 (dd, J = 11.3, 6.5 Hz, 1H, H-6b), 2.75 (s, 4H,
2CH2), 2.08 (s, 3H, COCH3), 2.07 (s, 3H, COCH3).
13C NMR (126
MHz, CDCl3) δ 171.0 (2 NHS CO), 170.6 (COCH3), 170.1
(COCH3), 128.8 (C-3), 125.9 (C-2), 97.5 (C-1), 68.3 (C-5), 61.9
(C-4), 61.8 (C-6), 25.5 (2 CH2), 20.8 (COCH3), 20.7 (COCH3).
ESI-HRMS for C14H17NO8Na
+ (MNa+) calculated: 350.0852; found:
350.0862.
6-O-(4,6-di-O-acetyl-2,3-dideoxy-α-D-erythro-hex-2-enopyrano-
syl)-1,2:4,5-di-O-isopropylidene-α-D-galacopyranoside (4b). Fol-
lowing the general glycosylation procedure, donor 1b (50 mg, 0.18
mmol), B(C6F5)3 (5 mg 0.01 mmol) and acceptor 2e (36 mg, 0.14
mmol) to aﬀord following puriﬁcation by column chromatography
(Hexane:EtOAc, 8:1 to 4:1) 4b as a yellow oil (56 mg, 86%).
Spectroscopic data in agreement with literature.9b
4-O-(acetyl)-2,3,6-trideoxy-α-L-hex-2-enopyranosyl-(1 → 6)-
1,2;3,4-di-O-isopropylidene-α-D-galactopyranoside (4c). Following
the general glycosylation procedure, donor 1c (50 mg, 0.12 mmol),
B(C6F5)3 (6 mg 0.011 mmol), and acceptor 2e (46 mg, 0.10 mmol)
to aﬀord following puriﬁcation by silica gel column chromatography
(Hexane:EtOAc, 8:1 to 5:1) 4c as a yellow oil (52 mg, 71%). 1H
NMR (500 MHz, CDCl3) δ 6.14−5.95 (m, 2H, H-2′, H-3′), 5.53 (d,
J = 5.0 Hz, 1H, H-1), 5.10 (d, J = 1.8 Hz, 1H, H−I′), 4.92 (dd, J =
4.4, 2.5 Hz, 1H, H-4’), 4.60 (dd, J = 7.9, 2.4 Hz, 1H, H-3), 4.31 (dd, J
= 5.1, 2.4 Hz, 1H, H-2), 4.28−4.21 (m, 2H, H-5′, H-4), 3.99−3.91
(m, 2H, H-5, H-6a), 3.72−3.64 (m, 1H, H-6b), 2.10 (s, 3H,
COCH3), 1.53 (s, 3H, CCH3), 1.45 (s, 3H, CCH3), 1.33 (s, 5H,
CCH3), 1.22 (d, J = 6.6 Hz, 3H, CCH3).
13C NMR (126 MHz,
CDCl3) δ 170.7 (COCH3), 130.5 (C-3′), 125.8 (C-2′), 109.2
(CCH3), 108.5 (CCH3), 96.3 (C-1), 94.0 (C-1′), 71.1 (C-5′), 70.6
(C-3), 70.5 (C-2), 67.0 (C-5), 66.1 (C-6), 65.1 (C4′), 64.6 (C-4),
26.1 (CCH3), 26.0 (CCH3), 24.9 (CCH3), 24.5 (CCH3), 20.9
(COCH3), 15.9 (CCH3). ESI-HRMS for C20H30O9Na
+ (MNa+)
calculated: 437.1788; found: 437.1788.
6-O-(R-2,3-dihydro-2H-pyran-4-yl acetate)-1,2:4,5-di-O-isopro-
pylidene-α-D-galacopyranoside (4d). Following the general glyco-
sylation procedure, donor 1d (50 mg, 0.18 mmol), B(C6F5)3 (6 mg
0.011 mmol) and acceptor 2e (36 mg, 0.14 mmol) to aﬀord following
puriﬁcation by silica gel column chromatography (Hexane:EtOAc,
10:1 to 6:1) 4d as a colorless oil (56 mg, 75%). 1H NMR (400 MHz,
CDCl3) δ 6.09−5.99 (m, 2H, H-2′, H-3′), 5.54 (d, J = 5.1 Hz, 1H, H-
1), 5.09 (d, J = 2.3 Hz, 1H, H-1′), 4.95−4.91 (m, 1H, H-4′)), 4.59
(dd, J = 7.9, 2.4 Hz, 1H, H-3), 4.30 (dd, J = 5.1, 2.4 Hz, 1H, H-2),
4.23−4.15 (m, 2H, H-4, H-6a), 3.99 (ddd, J = 7.1, 4.8, 1.9 Hz, 1H, H-
5), 3.90−3.72 (m, 3H, H-6b, H-5a′, H-5b′), 2.08 (s, 3H, COCH3),
1.52 (s, 3H, CCH3), 1.43 (s, 3H CCH3), 1.32 (s, 6H, 2 CCH3).
13C
NMR (101 MHz, CDCl3) δ 170.6 (COCH3), 130.9 (C-3′), 124.7 C-
2′), 109.3 (CCH3), 108.5 (CCH3), 96.3 (C-1), 93.5 (C-1′), 71.2 (C-
4′), 70.7 (C-3), 70.4 (C-2), 67.4 (C-5), 67.3 (C-5′), 63.4 (C-4), 61.4
(C-6), 26.0 (CCH3), 26.0 (CCH3), 24.9 (CCH3), 24.5 (CCH3), 21.1
(COCH3).). ESI-HRMS for C19H28O9Na
+ (MNa+) calculated:
423.1631; found: 423.1623.
4-O-(acetyl)-2,3,6-trideoxy-α-L-hex-2-enopyranosyl-(1 → 6)-
1,2;3,4-di-O-isopropylidene-α-D-galactopyranoside (4e). Following
the general glycosylation procedure, donor 1e (50 mg, 0.12 mmol),
B(C6F5)3 (6 mg 0.011 mmol) and acceptor 2e (46 mg, 0.10 mmol) to
aﬀord following puriﬁcation by silica gel column chromatography
(Hexane:EtOAc, 15:1 to 8:1) 4e as a yellow oil (48 mg, 65%).
Spectroscopic data in agreement with literature.9b
3-N-Boc-propyl acetyl-2,3,6-trideoxy-α-L-hex-2-enopyranosyl
(4f). Following the general glycosylation procedure, donor 1e (50
mg, 0.12 mmol), B(C6F5)3 (6 mg 0.011 mmol), and acceptor 2l (31
mg, 0.10 mmol) to aﬀord following puriﬁcation by silica gel column
chromatography (Hexane:EtOAc, 5:1 to 3:1) 4f as a yellow oil (50
mg, 85%). 1H NMR (500 MHz, CDCl3) δ 1.24 (d, J = 6.6 Hz, 3H,
CCH3), 1.45 (s, 9H, OC(CH3)3), 1.80 (dt, J = 11.6, 5.9 Hz, 2H,
CH2), 2.12 (s, 3H, COCH3), 3.18−3.29 (m, 2H, NHCH2), 3.56 (dt, J
= 9.9, 6.0 Hz, 1H, OCHH), 3.82−3.87 (m, 1H. OCHH), 4.23 (qd, J
= 6.7, 2.3 Hz, 1H, H-5), 4.70 (s, 1H, NH), 4.93 (dd, J = 5.4, 2.5 Hz,
1H, H-4), 5.02 (d, J = 2.9 Hz, 1H, H-1), 6.02 (ddt, J = 9.9, 3.1, 0.7
Hz, 1H, H-2), 6.09 (ddd, J = 10.0, 5.4, 1.0 Hz, 1H, H-3). 13C NMR
(126 MHz, CDCl3) δ 170.7 (COCH3), 155.9 (NHCO), 130.3 (C-2),
125.9 (C-3), 94.3 (C-1), 69.5 (OC(CH3)3) 66.3 (OCH2), 65.0 (C-4),
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64.7 (C-5), 38.2 (NHCH2), 29.9 (CH2), 28.4 (OC(CH3)3),
20.9(COCH3), 16.1. ESI-HRMS for C16H27NO6Na
+ (MNa+)
calculated: 352.1736; found: 352.1748
(3-N-Boc-propyl)-acetyl-2,3,6-trideoxy-α-L-hex-2-enopyranosyl
(5). To a stirring solution of glycoside 4f (200 mg, 0.18 mmol) in 5
mL of methanol, 20 mol % K2CO3 (36 mg, 0.14 mmol) was added.
The solution was stirred at RT until the reaction was determined to
be complete by TLC. The reaction mixture was concentrated in vacuo
and the dried residue diluted in CHCl3 (20 mL) and washed with
water (20 mL), brine (20 mL), and dried over anhydrous MgSO4.
The organic phase was concentrated in vacuo and puriﬁed by silica gel
column chromatography (Hexane:EtOAc, 3:1 to 1:1) to aﬀord 5 as a
colorless oil (170 mg, 75%). 1H NMR (500 MHz, CDCl3) δ 1.30 (dd,
J = 6.7, 2.3 Hz, 3H, CCH3), 1.44 (s, 9H, OC(CH3)3), 1.79 (p, J = 6.9
Hz, 2H, CH2), 3.24 (s, 2H, NHCH2), 3.51−3.63 (m, 2H, OCHH, H-
4), 3.84 (dddd, J = 10.4, 9.3, 5.6, 2.8 Hz, 1H, OCHH), 4.11 (qd, J =
6.7, 3.2 Hz, 1H, H-5), 4.72 (s, 1H, NH), 4.95 (s, 1H, H-1), 5.84−5.92
(m, 1H, H-2), 6.15−6.22 (m, 1H, H-3). 13C NMR (126 MHz,
CDCl3) δ 155.9 (NHCO), 130.3 (C-3), 128.1 (C-2), 94.6 (C-1), 79.1
(OC(CH3)3), 66.4 (C-5), 66.2 (OCH2), 63.9 (C-4), 38.2 (NHCH2),
29.9 (CH2), 28.4 (OC(CH3)3), 16.1 (CCH3). ESI-HRMS for
C14H25NO5Na
+ (MNa+) calculated: 310.1630; found: 310.1629.
(3-N-Boc-propyl)-α-L-Rhodinoside (6). To a stirring solution of
glycoside 5 (100 mg 0.348 mmol) in 2 mL of a 1:6 mixture of ethyl
acetate;toluene at RT, 5 mol % of Rh−Al2O3 (25 mg) was added. The
reaction mixture was placed under a H2 atmosphere (balloon) and
was stirred at RT for 5h. The reaction mixture was ﬁltered through
diatomaceous earth and the ﬁltrate was concentrated under vacuum.
The dry residue was puriﬁed by silica gel column chromatography
(Hexane:EtOAc, 5:1 to 2:1) 6 as a colorless oil (77 mg, 76%). 1H
NMR (500 MHz, CDCl3) δ 4.87 (s, 1H, NH), 4.73−4.77 (m, 1H, H-
1), 3.90 (q, J = 6.7, 6.0 Hz, 1H, H-5), 3.70 (ddd, J = 9.9, 7.2, 5.1 Hz,
1H, OCHH), 3.55 (s, 1H, H-4), 3.39−3.48 (m, 1H, OCHH), 3.19
(dd, J = 26.9, 5.8 Hz, 2H, NHCH2), 2.08 (s, 1H, OH), 1.89−2.02 (m,
2H, H-2a, H-3a), 1.67−1.81 (m, 3H, H-3b, CH2), 1.48−1.55 (m, 1H,
H-2b), 1.41 (s, 9H, OC(CH3)3), 1.15 (d, J = 6.6 Hz, 3H, CCH3),
13C
NMR (126 MHz, CDCl3) δ 155.9 (NHCO), 97.2 (C-1), 73.9
(OC(CH3)3), 67.2 (C-5), 66.2 (C-4), 65.4 (OCH2), 38.7 (NHCH2),
29.5 (CH2), 28.4 (OC(CH3)3), 25.7 (C-3), 23.4 (C-2), 17.1 (CCH3).
ESI-HRMS for C14H27NO5Na
+ (MNa+) calculated: 312.1787; found:
312.1781.
(3-N-Boc-propyl)-α-L-Cineruloside (7). To a stirring solution of 5
(100 mg 0.348 mmol) in 2 mL of a 1:6 mixture of ethyl
acetate;toluene at RT, 5% Rh−Al2O3 (25 mg) was added. The
reaction mixture was placed under a H2 atmosphere (balloon) and
was stirred at room temperature for 5 h. The reaction mixture was
ﬁltered through diatomaceous earth, and the ﬁltrate was concentrated
under vacuum. To the dried residue, Dess-Martin periodinane (221
mg 0.52 mmol) in 5 mL CH2Cl2 solvent were added and the reaction
left to stir for another 5h at RT. The reaction mixture was ﬁltered
through diatomaceous earth, and the ﬁltrate was concentrated under
vacuum. The dry residue was puriﬁed by silica gel column
chromatography (Hexane:EtOAc, 4:1 to 2:1) 7 as a colorless oil
(77 mg, 76%). 1H NMR (500 MHz, CDCl3) δ 4.97 (t, J = 4.7 Hz, 1H,
H-1), 4.73 (s, 1H, NH), 4.24 (q, J = 6.7 Hz, 1H, H-5), 3.83 (ddd, J =
10.0, 6.8, 5.5 Hz, 1H, OCHH), 3.55 (ddd, J = 10.0, 6.5, 5.4 Hz, 1H,
OCHH), 3.25 (q, J = 6.0 Hz, 2H, NHCH2), 2.53 (ddd, J = 16.1, 8.0,
5.7 Hz, 1H, H-3b), 2.44 (ddd, J = 16.1, 8.7, 5.8 Hz, 1H, H-3a), 2.25−
2.32 (m, 1H, H-2a), 2.01 (dddd, J = 14.1, 8.3, 5.7, 4.3 Hz, 1H, H-2b),
1.75−1.85 (m, 2H, CH2), 1.44 (s, 9H, OC(CH3)3), 1.29 (d, J = 6.7
Hz, 3H, CCH3).
13C NMR (126 MHz, CDCl3) δ 210.3 (C-4, C2CO),
155.9 (NHCO), 96.8 (C-1), 79.2 (OC(CH3)3), 71.0 (C-5), 65.8
(OCH2), 38.3 (NHCH2), 33.6 (C-3), 29.8 (CH2), 29.0 (CH2), 28.4
(OC(CH3)3), 14.9 (CCH3). ESI-HRMS for C14H25NO5Na
+ (MNa+)
calculated: 310.1630; found: 310.1630.
(3-N-Boc-propyl)-α-L-Aculoside (8). To a ﬂask loaded with 5 (100
mg 0.18 mmol), Dess-Martin periodinane (221 mg 0.52 mmol) in 5
mL CH2Cl2 solvent was added and the reaction left to stir for 6 h at
RT. The reaction mixture was then ﬁltered through diatomaceous
earth, and the ﬁltrate was concentrated under vacuum. The dry
residue was puriﬁed by silica gel column chromatography
(Hexane:EtOAc, 5:1 to 3:1) 8 as a colorless oil (84 mg 86% yield).
1H NMR (500 MHz, CDCl3) δ 6.84 (dd, J = 10.2, 3.5 Hz, 1H, H-2),
6.09 (d, J = 10.4 Hz, 1H, H-3), 5.18 (d, J = 3.5 Hz, 1H, H-1), 4.67 (s,
1H, NH), 4.55 (q, J = 6.8 Hz, 1H, H-5), 3.92 (dt, J = 9.9, 6.0 Hz, 1H,
OCHH), 3.64 (dt, J = 9.9, 6.0 Hz, 1H, OCHH), 3.21−3.31 (m, 2H,
NHCH2), 1.83 (p, J = 6.6 Hz, 2H, CH2), 1.45 (s, 9H, OC(CH3)3),
1.40 (d, J = 6.8 Hz, 3H, CCH3),
13C NMR (126 MHz, CDCl3) δ
196.9 (C-4 CO), 155.9 (NHCO), 143.3 (C-2), 127.3 (C-3), 93.3 (C-
1), 70.4 (OC(CH3)3), 67.2 (C-5), 38.0 (CH2), 30.0 (CH2), 29.7
(CH2), 28.0, (OC(CH3)3), 15.3 (CCH3). ESI-HRMS for
C14H23NO5Na
+ (MNa+) calculated: 308.1474; found: 308.1461.
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-tri-O-benzyl-α-D-
lyxo-hexapyranosyl)-α-D-glucopyranoside (10a). Following the
general glycosylation procedure. Donor 9a (50 mg, 0.10 mmol),
B(C6F5)3 (3 mg 0.006 mmol), and acceptor 2a (42 mg, 0.09 mmol)
to aﬀord following puriﬁcation by column chromatography (Hex-
ane:EtOAc, 6:1 to 3:1) 10a as a colorless oil (82 mg, 88%).
Spectroscopic data in agreement with literature.9a
Benzyl 2-deoxy-3,4,6-tri-O-benzyl-α-D-lyxo-hexapyranoside
(10b). Following the general glycosylation procedure. Donor 9a (50
mg, 0.10 mmol), B(C6F5)3 (3 mg 0.006 mmol) and acceptor 2b (10
mg, 0.09 mmol) to aﬀord following puriﬁcation by column
chromatography (Hexane:EtOAc, 20:1 to 10:1) 10b as a colorless
oil (46 mg, 94%). Spectroscopic data in agreement with literature.9a
6-O-(3,4,6-tri-O-benzyl-α-D-lyxo-hexapyranosyl)-1,2,3,4-di-O-iso-
propylidene-α-D-galactopyranoside (10e). Following the general
glycosylation procedure. Donor 9a (50 mg, 0.10 mmol), B(C6F5)3 (3
mg 0.006 mmol), and acceptor 2e (23 mg, 0.09 mmol) to aﬀord
following puriﬁcation by column chromatography (Hexane:EtOAc,
6:1 to 4:1) 10e as a colorless oil (50 mg, 84%). Spectroscopic data in
agreement with literature.4
Methyl 3-O-benzyl-2-O-(2-deoxy-3,4,6-tri-O-benzyl-α-D-lyxo-
hexapyranosyl)-4,6-O-benzylidene-α-D-glucopyranoside (10g).
Following the general glycosylation procedure. Donor 9a (50 mg,
0.10 mmol), B(C6F5)3 (3 mg 0.006 mmol), and acceptor 2e (34 mg,
0.09 mmol) to aﬀord following puriﬁcation by column chromatog-
raphy (Hexane:EtOAc, 6:1 to 4:1) 10g as a colorless oil (45 mg,
62%). Spectroscopic data in agreement with literature.9a
3-O-(2-deoxy-3,4,6-Tri-O-benzyl-α-D-lyxo-hexapyranoside)-
1,2:5,6-di-O-isopropylidene-α-D-glucofuranoside (10h). Following
the general glycosylation procedure. Donor 9a (50 mg, 0.10 mmol),
B(C6F5)3 (3 mg 0.006 mmol) and acceptor 2h (23 mg, 0.09 mmol) to
aﬀord following puriﬁcation by column chromatography (Hexane:E-
tOAc, 6:1 to 3:1) 10h as a colorless oil (41 mg, 68%). Spectroscopic
data in agreement with literature.9d
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-Tri-O-tert-butyldi-
methylsilyl-α-D-lyxo-hexapyranosyl)-α-D-glucopyranoside (11b).
Following the general glycosylation procedure. Donor 9b (50 mg,
0.10 mmol), B(C6F5)3 (3 mg 0.006 mmol) and acceptor 2a (36 mg,
0.08 mmol) to aﬀord following puriﬁcation by column chromatog-
raphy (Hexane:EtOAc, 10:1 to 8:1) 11b as a colorless oil (68 mg,
92%). Spectroscopic data in agreement with literature.9a
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-tri-O-methoxy-
methyl ether-α-D-lyxo-hexapyranosyl)-α-D-glucopyranoside (11c).
Following the general glycosylation procedure, donor 9c (50 mg, 0.10
mmol), B(C6F5)3 (5 mg 0.009 mmol) and acceptor 2a (63 mg, 0.11
mmol) to aﬀord following puriﬁcation by silkica gel column
chromatography (Hexane:EtOAc, 7:1 to 5:1) 11c as a colorless oil
(71 mg, 71%). Spectroscopic data in agreement with literature.9a
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-4,6-O-[Bis(tert-butyl)-
silylene]-3-O-methoxymethyl ether-α-D-lyxo-hexapyranosyl)-α-D-
glucopyranoside (11d). Following the general glycosylation
procedure, donor 9d (50 mg, 0.10 mmol), B(C6F5)3 (4 mg 0.008
mmol) and acceptor 2a (53 mg, 0.11 mmol) to aﬀord following
puriﬁcation by silica gel column chromatography (Hexane:EtOAc,
10:1 to 7:1) 11d as a colorless oil (74 mg, 82%). 1H NMR (400
MHz, CDCl3) δ 7.31 (dddd, J = 20.0, 16.0, 8.5, 5.8 Hz, 15H, Ar−H),
5.02−4.93 (m, 3H, H-1′, PhCHH), 4.83−4.77 (m, 3H, PhCHH,
OCH-H), 4.74−4.65 (m, 2H, PhCHH, OCH-H), 4.61 (d, J = 3.5 Hz,
1H, H-1), 4.55 (d, J = 11.4 Hz, 1H, PhCHH), 4.38 (d, J = 2.0 Hz, 1H,
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H-4′), 4.05−3.96 (m, 3H, H-3, H-6a′, H-6b′), 3.88 (ddd, J = 12.2,
4.4, 2.7 Hz, 1H, H-3′), 3.78 (m, 2H, H-5, H-6a), 3.63 (d, J = 9.6 Hz,
1H, H-6b), 3.54 (dd, J = 9.7, 3.6 Hz, 1H, H-2), 3.51−3.45 (m, 1H, H-
4), 3.42 (d, J = 3.1 Hz, 4H, H-5′, CH2OCH3), 3.38 (s, 3H, OCH3),
2.18 (td, J = 12.4, 3.6 Hz, 1H, H-2a′), 1.82 (dd, J = 12.5, 4.7 Hz, 1H,
H-2b′), 1.04 (s, 18H, 2C(CH3)3). 13C NMR (101 MHz, CDCl3) δ
138.6 (Ar−C), 138.3 (Ar−C), 138.1 (Ar−C), 128.5 (Ar−C), 128.4
(Ar−C), 127.9 (Ar−C), 127.7 (Ar−C), 127.2 (Ar−C), 98.2 (C-1′),
97.9 (C-1), 95.0 (OCH2−CH3), 82.2 (C-3), 80.1 (C-2), 78.1 (C-4),
75.8 (PhCH2), 74.8 (PhCH2), 73.3 (PhCH2), 72.1 (C-3′), 70.4 (C-
4′), 69.7 (C-5), 67.56 (2C, C-6′, C-5′), 65.9 (C-6), 55.7
(OCH2CH3), 55.1 (OCH3), 30.1 (C-2′), 27.6 (C(CH3)3), 27.4
(C(CH3)3), 23.4 (C(CH3)3), 20.8 (C(CH3)3). ESI-HRMS for
C44H62O11SiNa
+ (MNa+) calculated: 817.3959; found: 817.3965.
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-tri-O-benzyl-α-D-
lyxo-hexapyranosyl)-α-D-glucopyranoside (12a) and Methyl-6-O-
(4,6-di-O-acetyl-2,3-dideoxy-α-D-erythreo-hex-2-enopyranosyl)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside(12a′). Following the general
glycosylation procedure. Donor 11a (50 mg, 0.10 mmol), B(C6F5)3
(3 mg 0.006 mmol) and acceptor 2a (42 mg, 0.09 mmol) to aﬀord
following puriﬁcation by column chromatography (Hexane:EtOAc,
6:1 to 3:1) 12a as a colorless oil (44 mg, 54%) and 12a′ as a colorless
oil (7 mg, 10%). Spectroscopic data in agreement with literature.4c
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4-O-(1,1,3,3-tetraiso-
propyldisiloxane-1,3-diyl)-6-O-benzyl-α-D-erythro-hexapyranosyl)-
α-D-glucopyranoside (12b). Following the general glycosylation
procedure, donor 11b (50 mg, 0.10 mmol), B(C6F5)3 (3 mg 0.006
mmol), and acceptor 2a (36 mg, 0.08 mmol) to aﬀord following
puriﬁcation by silica gel column chromatography (Hexane:EtOAc,
12:1 to 8:1) 12b as a colorless oil (56 mg, 78%). Spectroscopic data
in agreement with literature.9a
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4-O-(1,1,3,3-tetraiso-
propyldisiloxane-1,3-diyl)-6-O-triisopropylsilyl-α-D-erythro-hexa-
pyranosyl)-α-D-glucopyranoside (12c). Following the general
glycosylation procedure, donor 11c (50 mg, 0.10 mmol), B(C6F5)3
(2 mg 0.005 mmol) and acceptor 2a (32 mg, 0.07 mmol) to aﬀord
following puriﬁcation by silica gel column chromatography (Hex-
ane:EtOAc, 12:1 to 8:1) 12c as a colorless oil (51 mg, 73%).
Spectroscopic data in agreement with literature.9a
6-O-(2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-6-
O-triisopropylsilyl-α-D-erythro-hexapyranosyl)-1,2,3,4-di-O-isopro-
pylidene-α-D-galactopyranoside (13). Following the general glyco-
sylation procedure, donor 11c (50 mg, 0.10 mmol), B(C6F5)3 (2 mg
0.005 mmol), and acceptor 2e (18 mg, 0.07 mmol) to aﬀord following
puriﬁcation by column chromatography (Hexane:EtOAc, 16:1 to
10:1) 13 as a colorless oil (48 mg, 86%). 1H NMR (400 MHz,
CDCl3) δ 0.83−1.18 (m, 49H, 7× SiCH(CH3)2), 1.32 (s, 6H, 2
O2CCH3), 1.43 (s, 3H, O2CCH3), 1.51 (s, 3H, O2CCH3), 1.66 (ddd,
J = 13.3, 11.4, 3.7 Hz, 1H, H-2a′), 2.10 (dd, J = 12.9, 5.3 Hz, 1H, H-
2b′), 3.49 (dd, J = 9.4, 8.3 Hz, 1H, H-4′), 3.54−3.61 (m, 1H, H-5′),
3.65 (dd, J = 10.7, 6.2 Hz, 1H, H-6b′), 3.79 (ddd, J = 17.8, 10.7, 6.4
Hz, 2H, H-6b, H-6a′), 3.97 (td, J = 6.5, 1.6 Hz, 1H, H-5), 4.00−4.08
(m, 2H, H-6a, H-3′), 4.20 (dd, J = 7.9, 1.8 Hz, 1H, H-4), 4.30 (dd, J =
5.0, 2.4 Hz, 1H, H-2), 4.60 (dd, J = 7.9, 2.3 Hz, 1H, H-3), 4.95 (d, J =
3.1 Hz, 1H, H-1′), 5.51 (d, J = 5.0 Hz, 1H, H-1). 13C NMR (101
MHz, CDCl3) δ 109.2 (O2CCH3), 108.4 (O2CCH3), 96.3 (C-1), 96.0
(C-1′), 74.6 (C-4′), 73.4 (C-5′), 71.6 (C-3′), 71.1 (C-4), 70.7 (2C,
C-2, C-3), 65.5 (C-5), 64.5 (C-6′), 63.3 (C-6), 38.0 (C-2′), 26.0
(O2CCH3), 25.9 (O2CCH3), 24.9 (O2CCH3), 24.4 (O2CCH3), 18.0,
17.9, 17.6, 17.4, 17.37, 17.3, 17.2 (Si(CH(CH3)2)), 13.0, 12.8, 12.4,
12.3, 12.0 (Si(CH(CH3)2)). ESI-HRMS for C39H76O11Si3Na
+
(MNa+) calculated: 827.4593; found: 827.4586
Methyl-3-O-benzyl-2-O-(2-deoxy-3,4-O-(1,1,3,3-tetraisopropyldi-
siloxane-1,3-diyl)-6-O-triisopropylsilyl-α-D-erythro-hexapyranosyl)-
4,6-O-benzylidene-α-D-glucopyranoside (14). Following the general
glycosylation procedure, donor 11c (50 mg, 0.10 mmol), B(C6F5)3 (2
mg 0.005 mmol), and acceptor 2g (26 mg, 0.07 mmol) to aﬀord
following puriﬁcation by column chromatography (Hexane:EtOAc,
10:1 to 5:1) 14 as a colorless oil (41 mg, 64%). Spectroscopic data in
agreement with literature.9a
Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-tri-O-benzyl-(axial/
equatorial)2-2H-α-D-lyxo-hexapyranosyl)-α-D-glucopyranoside
(16a/16b). Following the General Glycosylation Procedure, galactal 9
(50 mg, 0.120 mmol), B(C6F5)3 (3 mg 0.006 mmol), and acceptor 2a
(42 mg, 0.090 mmol). Following puriﬁcation by silica gel column
chromatography (8:1 to 4:1, Hexane:EtOAc) to aﬀord glycoside 16a/
16b as an oil (70 mg, 88%).9a
Hexaﬂuoroisopropayl-4,6-di-O-acetyl-2,3-dideoxy-α-D-threo-
hex-2-enopyranoside (18). Following the General Glycosylation
Procedure, galactal 1a (50 mg, 0.18 mmol), B(C6F5)3 (5 mg 0.009
mmol) acceptor 17 (42 mg, 0.090 mmol) at 45°C. Following
puriﬁcation by silica gel column chromatography (6:1 to 4:1,
Hexane:EtOAc) product 18 was obtained as an oil (45 mg, 87%).
1H NMR (500 MHz, CDCl3) δ 6.29 (ddd, J = 10.0, 5.7, 1.2 Hz, 1H,
H-3), 6.09 (dd, J = 10.0, 3.0 Hz, 1H, H-2), 5.34 (d, J = 2.6 Hz, 1H, H-
1), 5.08 (dd, J = 5.7, 2.5 Hz, 1H, H-4), 4.63 (hept, J = 5.4 Hz, 1H,
HC(CF3)2), 4.35 (ddd, J = 7.3, 4.6, 2.4 Hz, 1H, H-5), 4.30 (dd, J =
11.6, 4.6 Hz, 1H, H-6a), 4.18 (dd, J = 11.6, 7.5 Hz, 1H, H-6b), 2.09
(s, 3H, COCH3), 2.07 (s, 3H, COCH3).
13C NMR (126 MHz,
CDCl3) δ 170.5 (COCH3), 170.1 (COCH3), 127.9(C-2), 126.9 (C-
3), 122.9 (CF3), 122.2 (CF3), 94.8 (C-1), 71.6−71.1 (C(CF3)2), 68.1
(C-5), 62.4 (C-6), 62.1 (C-4), 20.7 (COCH3), 20.5 (COCH3).
19F
NMR (470 MHz, CDCl3) δ −73.52 (m, CF3), −73.61 (m, CF3). ESI-
HRMS for C13H14F6O6Na
+ (MNa+) calculated: 403.0592; found:
403.0600.
Hexaﬂuoroisopropayl-2-deoxy-3,4,6-tri-O-benzyl-α-D-lyxo-hexa-
pyranoside (19). Following the General Glycosylation Procedure,
galactal 9a (50 mg, 0.120 mmol), B(C6F5)3 (3 mg 0.006 mmol)
acceptor 17 (42 mg, 0.090 mmol) at RT. Following puriﬁcation by
silica gel column chromatography (12:1 to 8:1, Hexane:EtOAc)
product 19 was obtained as an oil (48 mg, 92%). 1H NMR (500
MHz, CDCl3) δ 7.46−7.23 (m, 15H, Ar−H), 5.28 (d, J = 3.6 Hz, 1H,
H-1), 4.97 (d, J = 11.5 Hz, 1H, PhCHH), 4.67−4.61 (m, 3H,
PhCHH. PhCHH), 4.50 (q, J = 11.9 Hz, 3H, PhCHH, HC(CF3)2),
4.06−3.99 (m, 2H, H-4, H-5), 3.95 (ddd, J = 12.1, 4.6, 2.3 Hz, 1H, H-
3), 3.63 (dd, J = 9.3, 7.0 Hz, 1H, H-6a), 3.58 (dd, J = 9.3, 5.9 Hz, 1H,
H-6b), 2.37 (td, J = 12.7, 3.9 Hz, 1H, H-2a), 2.19 (dd, J = 13.2, 4.6
Hz, 1H, H-2b). 13C NMR (126 MHz, CDCl3) δ 138.6 (Ar−C), 138.1
(Ar−C), 138.0 (Ar−C), 128.5 (Ar−C), 128.4 (Ar−C), 128.3 (Ar−
C), 128.2 (Ar−C), 127.7 (Ar−C), 127.7 (Ar−C), 127.6 (Ar−C),
127.6 (Ar−C), 127.4 (Ar−C), 122.4 (CF3). 120.2 (CF3), 100.0 (C-
1), 74.4 (PhCH2), 73.8 (C-3), 73.4 (PhCH2), 72.5 (C-4), 71.5
(C(CF3)2) 71.4 (C-5), 70.7 (PhCH2), 68.8 (C-6), 30.2 (C-2).
19F
NMR (470 MHz, CDCl3) −73.24 (m, CF3), −73.40 (m, CF3). ESI-
HRMS for C30H30F6O5Na
+ (MNa+) calculated: 607.1895;
found:607.1903.
Synthesis of Methyl-2,3,4-tri-O-benzyl-6-O-(2-deoxy-3,4,6-tri-O-
benzyl-α/b-D-lyxohexapyranosyl)-α-D-glucopyranoside (10a). The
glycosyl donor 9a (1 equiv) and acceptor 2a (0.83 equiv) were
weighed into a microwave vial and placed under vacuum for 1 h, after
which time the microwave vial was ﬁlled with N2. A solution mixture
containing (R)-3,3′-Bis[3,5-bis(triﬂuoromethyl)phenyl]-1,1′-bi-
naphthyl-2,2′-diyl hydrogenphosphate (0.1 equiv) and thiourea (0.1
equiv) in anhydrous CH3CN (1 mL) was stirred for 30 min, before
adding it to the microwave vial containing 1a and 2a.The reaction
mixture was stirred at RT for 4 h and then was puriﬁed by silica gel
column chromatography (Hexane:EtOAc, 7:1 to 4:1) aﬀording
disaccharide 3a as a colorless oil (66 mg 70%, 4:1 α:β). The
spectroscopic data was in agreement with previously reported data.15
In Situ Anomerization Test of 10a in the Presence of 2a.
Disaccharide 10a (4:1 α:β, 1 equiv), acceptor monosaccharide 2a (1
equiv), and B(C6F5)3 (5 mol %) were weighed into an oven-dried
microwave vial, sealed and placed under vacuum for 1 h. Then the vial
was ﬁlled with N2 followed by the addition of ∼1.0 mL of anhydrous
toluene. The solutions were stirred and heated at 50 °C for 2 h
without observing any change in the anomeric ratio (4:1 α/β) as
monitored by NMR of the crude mixture.
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